Members Login
Username 
 
Password 
    Remember Me  
Post Info TOPIC: Obesity Management Market: Global Industry Analysis and Forecast 2020 2027


Senior Member

Status: Offline
Posts: 167
Date:
Obesity Management Market: Global Industry Analysis and Forecast 2020 2027
Permalink   


Obesity Management Market Overview

The global obesity management market size is anticipated to expand at 8.4% CAGR during the assessment period (2015-2022) owing to the increasing patient population, asserts Market Research Future (MRFR). Obesity refers to the illness in ones body in which the body gain excess fat, and that can affect the health negatively. Obesity leads to diseases such as hypertension, diabetes, heart disease, and several others. According to the World Health Organization, over 41 million children under the age of 5 were suffering from overweight, and 600 million adults were suffering from obesity back in 2014.

The global obesity management market size is expanding at a swift pace owing to the growing patient population and research and development activities done by the market players. For instance, researchers at the University of Liverpool had helped to introduce a new treatment for obesity in 2015. With the growing initiatives by the market players in collaboration with the government to raise awareness about the adverse impact of obesity on health, the market is expected to stimulate over the assessment period. The growing awareness of weight management techniques is also likely to augment the global market during the forecast period. Moreover, with the growth in nuclear families and the rising working population, there has been an increasing demand for inexpensive fast food and easily accessible takeaway meals which are predicted to trigger the market growth in the coming years.

On the flip side, availability of low-cost alternatives, post-surgical side effects, and high cost of customization are the major factors restraining the market growth during the assessment period.

Request Free Sample Copy at:

https://www.marketresearchfuture.com/sample_request/2690

Obesity Management Market Segmentation

The global obesity management market size has been segmented on the basis of prescription weight-loss medication, surgery, end-user, and region.

By mode of prescription weight-loss, the global obesity management market has been segmented into lorcaserin (Belviq), orlistat (Xenical), bupropion and naltrexone (Contrave), phentermine and topiramate (Qsymia), liraglutide (Saxenda), and others.

By mode of surgery, the market has been segmented into laparoscopic adjustable gastric banding (LAGB), gastric bypass surgery, biliopancreatic diversion with duodenal switch, and others. Among these, the segment for gastric bypass surgery is predicted to be the fastest growing market due to factors such as improved psychological status, faster recovery time, and improved longevity.

By mode of end-user, the market has been segmented into exercise, dietary changes, and others.

Obesity Management Market Regional Analysis

Geographically, the obesity management market spans across regions namely, North America, Europe, Asia Pacific, and Rest-of-the-World.

Among all the regions, the Asia Pacific region is believed to grow at a rapid pace due to lack of physical activity, poor diet, and unhealthy life balance. The government in this region is focusing on advanced treatment and latest technologies, thus initiating new R&D programs for development of new drugs. Moreover, countries like India and China are focused on market players due to growing purchasing power and huge patient population compared to other countries in this region.

North America is anticipated to be the largest market for obesity management globally due to the high presence of obesity population and developed treatment options. For instance, according to CDC, over 37.9 % of adults were suffering from obesity between 2013 and 2014 and over 70.7% of adults aged 20 years and above were suffering from overweight.

Obesity Management Market Players

Globus Medical, Inc. (U.S.)

Depuy Synthes Inc. (Johnson & Johnson) (U.S.)

Smith & Nephew plc. (UK)

NuVasive, Inc. (U.S.)

Stryker Corporation (U.S.)

Integra LifeSciences Holdings Corporation (U.S.)

Zimmer Biomet Holdings, Inc. (U.S.)

Medtronic, plc (Ireland)

Wright Medical Group N.V. (Netherlands)

The Orthopedic Implant Company (U.S.)

Aesculap Implant Systems (U.S.)

Conmed Corporation (U.S.)

BioTek Instruments, Inc. (U.S.)

Arthrocare Corporation (U.S.)

among others are some key companies in the global Obesity Management that are listed by MRFR for market research.

Browse Detailed TOC with COVID-19 Impact Analysis at:

https://www.marketresearchfuture.com/reports/obesity-management-market-2690

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 628 258 0071

Email: sales@marketresearchfuture.com



Attachments
__________________
Page 1 of 1  sorted by
Quick Reply

Please log in to post quick replies.

Tweet this page Post to Digg Post to Del.icio.us


Create your own FREE Forum
Report Abuse
Powered by ActiveBoard